Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromelain and montelukast in hospitalized patients with COVID-19
IRCT20150725023332N3Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of montelukast in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Inflammatory factors and Immunological factors. Started Apr 2020; status: completed.
02
Drugs
montelukast
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20150725023332N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150725023332N3.